These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15286106)

  • 21. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects.
    Bokan I; Bill JS; Schlagenhauf U
    J Clin Periodontol; 2006 Dec; 33(12):885-93. PubMed ID: 17092241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
    Sculean A; Kiss A; Miliauskaite A; Schwarz F; Arweiler NB; Hannig M
    J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
    Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
    J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of infrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane.
    Silvestri M; Sartori S; Rasperini G; Ricci G; Rota C; Cattaneo V
    J Clin Periodontol; 2003 May; 30(5):386-93. PubMed ID: 12716329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review.
    Koop R; Merheb J; Quirynen M
    J Periodontol; 2012 Jun; 83(6):707-20. PubMed ID: 22050544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration.
    Sculean A; Donos N; Schwarz F; Becker J; Brecx M; Arweiler NB
    J Clin Periodontol; 2004 Jul; 31(7):545-9. PubMed ID: 15191590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enamel matrix derivative in the treatment of human intrabony osseous defects.
    Okuda K; Momose M; Miyazaki A; Murata M; Yokoyama S; Yonezawa Y; Wolff LF; Yoshie H
    J Periodontol; 2000 Dec; 71(12):1821-8. PubMed ID: 11156038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study.
    Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB
    J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four-year results following treatment of intrabony periodontal defects with an enamel matrix protein derivative: a report of 46 cases.
    Sculean A; Chiantella GC; Miliauskaite A; Brecx M; Arweiler NB
    Int J Periodontics Restorative Dent; 2003 Aug; 23(4):345-51. PubMed ID: 12956478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodontal regeneration - intrabony defects: a systematic review from the AAP Regeneration Workshop.
    Kao RT; Nares S; Reynolds MA
    J Periodontol; 2015 Feb; 86(2 Suppl):S77-104. PubMed ID: 25216204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.
    Meyle J; Hoffmann T; Topoll H; Heinz B; Al-Machot E; Jervøe-Storm PM; Meiss C; Eickholz P; Jepsen S
    J Clin Periodontol; 2011 Jul; 38(7):652-60. PubMed ID: 21564156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orthodontic treatment of periodontally involved teeth after tissue regeneration.
    Ghezzi C; Masiero S; Silvestri M; Zanotti G; Rasperini G
    Int J Periodontics Restorative Dent; 2008 Dec; 28(6):559-67. PubMed ID: 19146051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft.
    Hoffmann T; Al-Machot E; Meyle J; Jervøe-Storm PM; Jepsen S
    Clin Oral Investig; 2016 Mar; 20(2):357-64. PubMed ID: 26174080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of enamel matrix derivatives to bone substitutes for the treatment of intrabony defects: A systematic review, meta-analysis and trial sequential analysis.
    Troiano G; Laino L; Zhurakivska K; Cicciù M; Lo Muzio L; Lo Russo L
    J Clin Periodontol; 2017 Jul; 44(7):729-738. PubMed ID: 28477366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.